Comment by mrweasel

> It would be easier to squeeze Novo

Didn't Novo pretty much tell congress that the only reason why the high price for Ozempic and Wegovy is the US system of middlemen and that lowering it's prices won't necessarily benefit the patients? The CNN reporting from the hearing is pretty interesting[1]. According to Novo Nordisk when they tried lowering the prices of their insulin product, pharmacy benefit managers dropped their products out of coverage, resulting in fewer people having access to the medication overall.

It's not entirely clear that Novo Nordisk is the company that needs to be squeezed.

1) https://edition.cnn.com/2024/09/24/health/ozempic-novo-nordi...